Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

NCT03768375 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma of the Extrahepatic Bile Duct
Gallbladder Cancer

Interventions

BIOLOGICAL: conventional chemotherapy(FORFIRINOX) combined with target agents
BIOLOGICAL: conventional chemotherapy(FORFIRINOX)

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]